196 related articles for article (PubMed ID: 33509286)
1. Efficacy of a multivalent vaccine against Fasciola hepatica infection in sheep.
Zafra R; Buffoni L; Pérez-Caballero R; Molina-Hernández V; Ruiz-Campillo MT; Pérez J; Martínez-Moreno Á; Martínez Moreno FJ
Vet Res; 2021 Jan; 52(1):13. PubMed ID: 33509286
[TBL] [Abstract][Full Text] [Related]
2. Vaccination with cathepsin L phage-exposed mimotopes, single or in combination, reduce size, fluke burden, egg production and viability in sheep experimentally infected with Fasciola hepatica.
Villa-Mancera A; Alcalá-Canto Y; Reynoso-Palomar A; Olmedo-Juárez A; Olivares-Pérez J
Parasitol Int; 2021 Aug; 83():102355. PubMed ID: 33872793
[TBL] [Abstract][Full Text] [Related]
3. The recombinant gut-associated M17 leucine aminopeptidase in combination with different adjuvants confers a high level of protection against Fasciola hepatica infection in sheep.
Maggioli G; Acosta D; Silveira F; Rossi S; Giacaman S; Basika T; Gayo V; Rosadilla D; Roche L; Tort J; Carmona C
Vaccine; 2011 Nov; 29(48):9057-63. PubMed ID: 21939713
[TBL] [Abstract][Full Text] [Related]
4. Pathological, immunological and parasitological study of sheep vaccinated with the recombinant protein 14-3-3z and experimentally infected with Fasciola hepatica.
Pérez-Caballero R; Siles-Lucas M; González-Miguel J; Martínez-Moreno FJ; Escamilla A; Pérez J; Martínez-Moreno A; Buffoni L
Vet Immunol Immunopathol; 2018 Aug; 202():115-121. PubMed ID: 30078585
[TBL] [Abstract][Full Text] [Related]
5. Fasciola hepatica antioxidant and protease-inhibitor cocktail recombinant vaccines administered five times elicit potent and sustained immune responses in sheep but do not confer protection.
Cwiklinski K; McEvoy A; López Corrales J; Jewhurst H; Calvani NED; De Marco Verissimo C; Dorey AL; Keane OM; Dalton JP; Lalor R
Vet Parasitol; 2023 Nov; 323():110049. PubMed ID: 37826973
[TBL] [Abstract][Full Text] [Related]
6. The effect of Quil A adjuvant on the course of experimental Fasciola hepatica infection in sheep.
Haçariz O; Sayers G; McCullough M; Garrett M; O'Donovan J; Mulcahy G
Vaccine; 2009 Jan; 27(1):45-50. PubMed ID: 18977261
[TBL] [Abstract][Full Text] [Related]
7. Glutathione S-transferase. Novel vaccine against Fasciola hepatica infection in sheep.
Sexton JL; Milner AR; Panaccio M; Waddington J; Wijffels G; Chandler D; Thompson C; Wilson L; Spithill TW; Mitchell GF
J Immunol; 1990 Dec; 145(11):3905-10. PubMed ID: 1978849
[TBL] [Abstract][Full Text] [Related]
8. The addition of a new immunomodulator with the adjuvant adaptation ADAD system using fatty acid binding proteins increases the protection against Fasciola hepatica.
López-Abán J; Nogal-Ruiz JJ; Vicente B; Morrondo P; Diez-Baños P; Hillyer GV; Martínez-Fernández AR; Feliciano AS; Muro A
Vet Parasitol; 2008 May; 153(1-2):176-81. PubMed ID: 18308471
[TBL] [Abstract][Full Text] [Related]
9. Th1/Th2 balance in the liver and hepatic lymph nodes of vaccinated and unvaccinated sheep during acute stages of infection with Fasciola hepatica.
Pacheco IL; Abril N; Morales-Prieto N; Bautista MJ; Zafra R; Escamilla A; Ruiz MT; Martínez-Moreno A; Pérez J
Vet Parasitol; 2017 Apr; 238():61-65. PubMed ID: 28385539
[TBL] [Abstract][Full Text] [Related]
10. Moderate protection is induced by a chimeric protein composed of leucine aminopeptidase and cathepsin L1 against Fasciola hepatica challenge in sheep.
Ortega-Vargas S; Espitia C; Sahagún-Ruiz A; Parada C; Balderas-Loaeza A; Villa-Mancera A; Quiroz-Romero H
Vaccine; 2019 May; 37(24):3234-3240. PubMed ID: 31036453
[TBL] [Abstract][Full Text] [Related]
11. Identification of protective peptides of Fasciola hepatica-derived cathepsin L1 (FhCL1) in vaccinated sheep by a linear B-cell epitope mapping approach.
Buffoni L; Garza-Cuartero L; Pérez-Caballero R; Zafra R; Javier Martínez-Moreno F; Molina-Hernández V; Pérez J; Martínez-Moreno Á; Mulcahy G
Parasit Vectors; 2020 Jul; 13(1):390. PubMed ID: 32736582
[TBL] [Abstract][Full Text] [Related]
12. Attempted immunisation of sheep against Fasciola hepatica using gamma-irradiated metacercariae.
Creaney J; Spithill TW; Thompson CM; Wilson LR; Sandeman RM; Parsons JC
Int J Parasitol; 1995 Jul; 25(7):853-6. PubMed ID: 7558572
[TBL] [Abstract][Full Text] [Related]
13. Vaccine potential of inclusion bodies containing cysteine proteinase of Fasciola hepatica in calves and lambs experimentally challenged with metacercariae of the fluke.
Wedrychowicz H; Kesik M; Kaliniak M; Kozak-Cieszczyk M; Jedlina-Panasiuk L; Jaros S; Plucienniczak A
Vet Parasitol; 2007 Jun; 147(1-2):77-88. PubMed ID: 17481823
[TBL] [Abstract][Full Text] [Related]
14. Liver fluke vaccines in ruminants: strategies, progress and future opportunities.
Toet H; Piedrafita DM; Spithill TW
Int J Parasitol; 2014 Oct; 44(12):915-27. PubMed ID: 25200351
[TBL] [Abstract][Full Text] [Related]
15. An attempt to vaccinate sheep against Fasciola hepatica using a juvenile fluke antigen sheep antibody complex.
Sandeman RM; Howell MJ; Campbell NJ
Res Vet Sci; 1980 Sep; 29(2):255-9. PubMed ID: 6110229
[TBL] [Abstract][Full Text] [Related]
16. Phage display-based vaccine with cathepsin L and excretory-secretory products mimotopes of Fasciola hepatica induces protective cellular and humoral immune responses in sheep.
Villa-Mancera A; Olivares-Pérez J; Olmedo-Juárez A; Reynoso-Palomar A
Vet Parasitol; 2021 Jan; 289():109340. PubMed ID: 33373968
[TBL] [Abstract][Full Text] [Related]
17. Vaccination of mice and sheep with Fh12 FABP from Fasciola hepatica using the new adjuvant/immunomodulator system ADAD.
Martínez-Fernández AR; Nogal-Ruiz JJ; López-Abán J; Ramajo V; Oleaga A; Manga-González Y; Hillyer GV; Muro A
Vet Parasitol; 2004 Dec; 126(3):287-98. PubMed ID: 15567592
[TBL] [Abstract][Full Text] [Related]
18. The failure of a DNA prime/protein boost regime and CTLA-4 mediated targeting to improve the potency of a DNA vaccine encoding Fasciola hepatica phosphoglycerate kinase in sheep.
Wesołowska A; Basałaj K; Zawistowska-Deniziak A; Januszkiewicz K; Kozak Ljunggren M; Jedlina L; Wędrychowicz H
Vet Immunol Immunopathol; 2019 Nov; 217():109941. PubMed ID: 31550657
[TBL] [Abstract][Full Text] [Related]
19. Intranasal delivery of a formulation containing stage-specific recombinant proteins of Fasciola hepatica cathepsin L5 and cathepsin B2 triggers an anti-fecundity effect and an adjuvant-mediated reduction in fluke burden in sheep.
Norbury LJ; Basałaj K; Zawistowska-Deniziak A; Sielicka A; Wilkowski P; Wesołowska A; Smooker PM; Wędrychowicz H
Vet Parasitol; 2018 Jul; 258():14-23. PubMed ID: 30105973
[TBL] [Abstract][Full Text] [Related]
20. Molecular characterisation and vaccine efficacy of two novel developmentally regulated surface tegument proteins of Fasciola hepatica.
McCusker P; Toet H; Rathinasamy V; Young N; Beddoe T; Anderson G; Dempster R; McVeigh P; McCammick E; Wells D; Mousley A; Marks NJ; Maule AG; Spithill TW
Vet Parasitol; 2020 Oct; 286():109244. PubMed ID: 32971381
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
